Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Image forming apparatus capable of timely starting different image formation mode
Personalized health communication system
Process for filtering interferograms obtained from SAR images acquired on the same area
System and method for organizing, processing and presenting information
Bacterial superantigen vaccines
Pet fish burial pod
Protecting a gaming machine from rogue code
  Randomly Featured Patents
Hydrophilic DLC on substrate with UV exposure
AC/DC boost converter
Hydrofining process for hydrocarbon containing feed streams
Apparatus and method for suppressing the input current inrush for a voltage converter in a pre-charge stage
Physical condition monitoring system for detection in remote places
Sleeper for the attachment of covering material to a surface
Cassette recorder that can take cassettes of various sizes
Dual flapper valve assembly
Microwave dryer for washing machine
EMF signature device